SCHEMBL19626501

SCHEMBL19626501

CCOc1ccc2cc(-c3csc(C)n3)ccc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25A P30304 2/20 0.61
CDC25B P30305 2/20 0.61
CDC25C P30307 2/20 0.61
DUSP3 P51452 2/20 0.61
ATP4A P20648 2/20 0.52
ATP4B P51164 2/20 0.52
HTT P42858 1/20 0.52
RECQL P46063 3/20 0.51
GAA P10253 2/20 0.51
MAPT P10636 2/20 0.51
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 1/20 0.51
POLB P06746 1/20 0.51
HPGD P15428 1/20 0.51
ESR2 Q92731 1/20 0.51
CYP11B1 P15538 2/20 0.49
CYP11B2 P19099 2/20 0.49
CYP19A1 P11511 1/20 0.49
ROCK2 O75116 1/20 0.49
PIM1 P11309 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19626484 0.85 TSHR (0.57) CDC25ACDC25BCDC25CDUSP3HTT
SCHEMBL19625424 0.85 CDC25A (0.57) CDC25ACDC25BCDC25CDUSP3MAPT
SCHEMBL12647916 0.78 NPC1 (0.67) CDC25ACDC25BCDC25CDUSP3HTT
SCHEMBL19626500 0.78 MAPT (0.54) CDC25ACDC25BCDC25CDUSP3ATP4A
SCHEMBL19627006 0.77 MAPT (0.53) CDC25ACDC25BCDC25CDUSP3ATP4A
SCHEMBL19626562 0.77 HTT (0.56) CDC25ACDC25BCDC25CDUSP3ATP4A
SCHEMBL19626563 0.77 HTT (0.59) CDC25ACDC25BCDC25CDUSP3ATP4A
SCHEMBL19626604 0.77 HTT (0.53) CDC25ACDC25BCDC25CDUSP3ATP4A
SCHEMBL17626276 0.77 CDC25A (0.51) CDC25ACDC25BCDC25CDUSP3MAPT
SCHEMBL19627017 0.74 MAPT (0.50) CDC25ACDC25BCDC25CDUSP3ATP4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 CDC25A 3229/4885CDC25B 3454/4885CDC25C 3034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.